CD27 and neoplasm: The analysis showed that tumor-infiltrating CD27+Ly6C− γδ T cells increased expression of each marker when compared to CD27+Ly6C− γδ T cells in the spleen, LN, or lung, indicating that CD27+Ly6C− γδ T cells are modified by tumors.